TARGET CTCA is a joint venture between EMERGE and the cardiology research team aiming to recruit patients with suspected ACS across NHS Lothian and NHS Greater Glasgow and Clyde. The study aims to recruit 2270 participants.
This is a randomised control trial funded by the British Heart Foundation, aiming to evaluate troponin in acute chest pain to risk stratify and guide effective use of computed tomography coronary angiography (CTCA).
Inclusion Criteria:
Exclusion Criteria:
Honorary Professor of Emergency Medicine & Clinical Director of the Emergency Department
Lead Research Nurse
Research Project Manager
Cardiology Research Nurse
TARGET CTCA is a joint venture between EMERGE and the cardiology research team aiming to recruit patients with suspected ACS across NHS Lothian and NHS Greater Glasgow and Clyde. The study aims to recruit 2270 participants. For further information, please contact the EMERGE team.
DASH is a randomised clinical trial investigating a treatment to reverse the effects of blood-thinning medications.
Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS) by laboratory analysis of biological samples from recreational drug users.
Identification of Novel Psychoactive Substances (IONA)